Deciphering the role of epigenetic modifications in fatty liver disease: A systematic review-Reference-Cited by-同舟云学术

Deciphering the role of epigenetic modifications in fatty liver disease: A systematic review

Published:2021-01-04 Issue:5 Volume:51 Page:
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:Eur J Clin Investigation

Author:

Zhang Xiaofang¹^ORCID,Asllanaj Eralda¹²,Amiri Masoud¹,Portilla‐Fernandez Eliana¹,Bramer Wichor M.³,Nano Jana⁴⁵,Voortman Trudy¹,Pan Qiuwei⁶^ORCID,Ghanbari Mohsen¹^ORCID

Affiliation:

1. Department of Epidemiology Erasmus MCErasmus University Medical Center Rotterdam the Netherlands

2. Institute for Community Medicine University Medicine Greifswald Greifswald Germany

3. Medical Library Erasmus MCErasmus University Medical Centre Rotterdam the Netherlands

4. Institute of Epidemiology Helmholtz Zentrum MünchenGerman Research Center for Environmental Health Neuherberg Germany

5. German Diabetes Center München‐Neuherberg Germany

6. Department of Gastroenterology and Hepatology Erasmus MCErasmus University Medical Center Rotterdam the Netherlands

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/eci.13479

Reference50 articles.

1. Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

2. Deregulated hepatic microRNAs underlie the association between non-alcoholic fatty liver disease and coronary artery disease

3. Epigenetic Modifications in the Biology of Nonalcoholic Fatty Liver Disease

4. Non-alcoholic fatty liver disease (NAFLD) is associated with dynamic changes in DNA hydroxymethylation

5. miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular and molecular alterations in a human hepatocellular in vitro model of nonalcoholic fatty liver disease development and stratification;Journal of Environmental Science and Health, Part C;2023-12-18

2. A crosstalk between epigenetic modulations and non-alcoholic fatty liver disease progression;Pathology - Research and Practice;2023-11

3. Comprehensive analysis of epigenetic and epitranscriptomic genes’ expression in human NAFLD;Journal of Physiology and Biochemistry;2023-08-25

4. Role of ammonia in NAFLD: An unusual suspect;JHEP Reports;2023-07

5. In silico analysis of the solute carrier (SLC) family in cancer indicates a link among DNA methylation, metabolic adaptation, drug response, and immune reactivity;Frontiers in Pharmacology;2023-06-15